ARTICLE | Clinical News
Voclera voclosporin regulatory update
January 10, 2011 8:00 AM UTC
Paladin submitted an NDS to Health Canada for Voclera voclosporin to treat moderate to severe psoriasis. Paladin has rights from Isotechnika to the transisomer of a cyclosporine analog that inhibits ...